PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
Turnover
16.67%
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.81%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$118M
AUM Growth
-$23.8M
(-17%)
Cap. Flow
-$7.97M
Cap. Flow
% of AUM
-6.74%
Top 10 Holdings %
Top 10 Hldgs %
26.86%
Holding
154
New
13
Increased
16
Reduced
54
Closed
16
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LiqTech
LIQT
|
+$2.24M |
| 2 |
JCP
J.C. Penney Company, Inc.
JCP
|
+$1.32M |
| 3 |
MEET
The Meet Group, Inc. Common Stock
MEET
|
+$1.3M |
| 4 |
Vericel Corp
VCEL
|
+$1.16M |
| 5 |
Sanofi
SNY
|
+$969K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EDAP TMS S.A.
FOCL
|
+$3.01M |
| 2 |
Rockwell Medical
RMTI
|
+$1.37M |
| 3 |
QUMU
Qumu Corp.
QUMU
|
+$1.37M |
| 4 |
CONMED
CNMD
|
+$1.14M |
| 5 |
Ring Energy
REI
|
+$1.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.79% |
| 2 | Technology | 17.46% |
| 3 | Miscellaneous | 11.41% |
| 4 | Industrials | 11.28% |
| 5 | Consumer Staples | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $5.32M | 4.5% |
88,455
-200
| -0.2% | -$13.1K |
2013 Q2
5 quarters
|
|
|
2
Rockwell Medical
RMTI
$30.9M
| $4.41M | 3.73% |
4,390
-1,215
| -22% | -$1.37M |
2013 Q2
5 quarters
|
|
3
NeoGenomics
NEO
$2.17B
| $4.25M | 3.59% |
814,980
+25,000
| +3% | +$128K |
2013 Q2
5 quarters
|
|
|
UPI
4
DELISTED
UROPLASTY INC-NEW
UPI
| $3.25M | 2.74% |
1,298,488
-11,523
| -0.9% | -$30.1K |
2013 Q2
5 quarters
|
|
5
Altimmune
ALT
$449M
| $2.62M | 2.21% |
4,906
-42
| -0.8% | -$22K |
2013 Q2
5 quarters
|
|
|
HILL
6
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $2.5M | 2.11% |
660,306
-11,975
| -2% | -$46.9K |
2013 Q2
5 quarters
|
|
7
Xtant Medical Holdings
XTNT
$44.7M
| $2.44M | 2.06% |
45,323
+5,121
| +13% | +$340K |
2013 Q2
5 quarters
|
|
|
CSII
8
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.43M | 2.05% |
102,700
-27,350
| -21% | -$778K |
2013 Q2
5 quarters
|
|
9
AI Financial Corp
AIFC
$55.9M
| $2.34M | 1.98% |
158,724
-5,000
| -3% | -$85.7K |
2013 Q2
5 quarters
|
|
|
SVU
10
DELISTED
SUPERVALU Inc.
SVU
| $2.24M | 1.89% |
35,776
| – | – |
2013 Q2
5 quarters
|
|
|
11
LiqTech
LIQT
$12.7M
| $2.08M | 1.75% |
+42,133
| New | +$2.24M |
2014 Q3
0 quarters
|
|
|
CRDC
12
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $2.01M | 1.7% |
187,778
-2,500
| -1% | -$28.3K |
2013 Q2
5 quarters
|
|
|
SPDC
13
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
| $1.95M | 1.64% |
707,500
| – | – |
2013 Q2
5 quarters
|
|
14
Pfizer
PFE
$166B
| $1.89M | 1.59% |
67,276
| – | – |
2013 Q2
5 quarters
|
|
15
Apple
AAPL
$5.01T
| $1.76M | 1.49% |
69,860
-700
| -1% | -$17.2K |
2013 Q3
4 quarters
|
|
16
Deluxe
DLX
$1.04B
| $1.72M | 1.46% |
31,242
| – | – |
2013 Q2
5 quarters
|
|
17
Baxter International
BAX
$12.8B
| $1.66M | 1.4% |
42,569
+368
| +0.9% | +$14.9K |
2013 Q2
5 quarters
|
|
18
Riot Platforms
RIOT
$5.67B
| $1.62M | 1.37% |
122,098
-18,927
| -13% | -$280K |
2013 Q2
5 quarters
|
|
|
WAVX
19
DELISTED
WAVE SYS CORP CL A NEW COM STK (DE)
WAVX
| $1.6M | 1.36% |
149,935
-15,330
| -9% | -$198K |
2013 Q2
5 quarters
|
|
|
GLUU
20
DELISTED
Glu Mobile Inc.
GLUU
| $1.6M | 1.35% |
309,500
-20,000
| -6% | -$112K |
2013 Q3
4 quarters
|
|
|
JCP
21
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.53M | 1.3% |
152,900
+134,400
| +726% | +$1.32M |
2014 Q2
1 quarter
|
|
22
CarParts.com
PRTS
$58M
| $1.51M | 1.28% |
53,610
-24,630
| -31% | -$763K |
2013 Q2
5 quarters
|
|
23
ePlus
PLUS
$2.47B
| $1.46M | 1.23% |
104,000
-6,000
| -5% | -$85.1K |
2013 Q2
5 quarters
|
|
24
INVE Technologies, Inc. Common Stock
INVE
$55.7M
| $1.41M | 1.19% |
105,095
-3,980
| -4% | -$52.4K |
2013 Q2
5 quarters
|
|
25
Eli Lilly
LLY
$1.08T
| $1.33M | 1.12% |
20,450
| – | – |
2013 Q2
5 quarters
|
|
Similar funds
AA
WA
AC
BCVI
HAP
RHIG
CWM
SI
Perkins Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Perkins Capital Management held 154 positions worth $118M, down 17% from $142M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Perkins Capital Management withdrew a net $7.97M in Q3 2014, closing 16 positions and reducing 54 holdings. Its most notable exit was EDAP TMS S.A., an estimated $3.01M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 43% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Perkins Capital Management opened a new position in LiqTech worth $2.08M.
- Perkins Capital Management's largest Q3 2014 buy was LiqTech: 42,133 shares worth $2.08M.
- Perkins Capital Management added most to J.C. Penney Company, Inc. in Q3 2014, an estimated $1.32M increase.
- Perkins Capital Management's biggest Q3 2014 reduction was Rockwell Medical, cutting an estimated $1.37M.
- Perkins Capital Management fully exited EDAP TMS S.A. in Q3 2014, selling an estimated $3.01M.
- Perkins Capital Management's ten largest holdings make up 27% of its $118M portfolio in Q3 2014.
- Perkins Capital Management opened 13 new positions and closed 16 in Q3 2014.
- Perkins Capital Management's portfolio value fell 17% quarter-over-quarter to $118M.
Based on Perkins Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.